GlassScriptPhysician profile
Jeffrey D Trachtenberg
NPI 1821070517
$5,485.46
in general payments reported to CMS, 2019-2025
29 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $407 · 2021: $220 · 2022: $1,072 · 2023: $932 · 2024: $1,037 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,418.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,559.55 | 2019-2024 | C3 Delivery System, Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Janssen Pharmaceuticals, INC | $551.59 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $485.26 | 2019-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $356.06 | 2019-2024 | Eluvia |
| Cook Medical LLC | $314.41 | 2019 | |
| Merck Sharp & Dohme LLC | $309.72 | 2023-2025 | Verquvo |
| Amgen INC. | $277.80 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $185.24 | 2022-2025 | Ruby Coil, Indigo System |
| Silk Road Medical, INC. | $172.12 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Pfizer INC. | $154.28 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $131.53 | 2021-2024 | Rotarexs 6 F X 135 Cm, Covera |
| Astrazeneca Pharmaceuticals LP | $120.87 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $116.85 | 2022-2023 | Eliquis |
| Philips North America LLC | $92.86 | 2024-2025 | Pioneer, Multi Modality Ivus Other Systems, (Br5) Peripheral Ivus |
| Lexicon Pharmaceuticals, INC. | $84.19 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $83.08 | 2025 | Treo Abdominal Stent-Graft System |
| Novartis Pharmaceuticals Corporation | $80.34 | 2022-2025 | |
| Cardiovascular Systems INC. | $72.08 | 2021 | |
| Endologix LLC | $68.29 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.68 | 2022-2023 | Jardiance |
| Davol INC. | $49.67 | 2024 | Covera |
| Becton, Dickinson and Company | $32.78 | 2024 | Lutonix Drug Coated Balloon |
| Novo Nordisk INC | $23.04 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $20.11 | 2019 | |
| Shockwave Medical, INC | $19.78 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals, LTD. | $19.51 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $15.12 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.12 | 2022 | |
| Osiris Therapeutics INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Trachtenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.